Pacira BioSciences, Inc. Tech Stack
Non-opioid pain management therapies for surgical and chronic pain
Pacira BioSciences develops non-opioid pain therapies delivered through advanced formulation technologies (controlled-release, multi-vesicular liposomes). The hiring mix—sales-heavy with targeted regulatory, biometrics, and payer accounts leadership—reflects a commercial-stage biotech executing market expansion. Active projects span M&A support, brand positioning through 2027, and surgical patient journey optimization, while pain points cluster around adoption barriers, pricing access, and field compliance—signals of a company scaling beyond early adopters into mainstream clinical practice.
Tech Stack 11 technologies
What Pacira BioSciences, Inc. Is Building
◆Challenges
- Inspection readiness
- Pricing and access challenges
- Complex m&a transactions
- Adoption barriers
- Growth opportunities
- Increasing sales in soft tissue community
- Operational governance
- Ensuring compliance training for field personnel
- Increasing adoption of zilretta
- Meeting revenue targets
▲Active Projects
- Cultural and career pathways initiatives
- Engagement survey
- M&a transaction support
- People priorities projects
- Contract drafting and negotiation
- 2027 brand planning
- Refining surgical patient customer journeys
- Congress strategy and tactics
- Biomarker correlation analyses
- Pharmacokinetic and pharmacodynamic evaluations
Hiring Activity
Department
Seniority
Notable leadership hires: Regulatory Affairs Director, Biometrics Director, Payer Accounts Director
